Evolution of Subclinical Hypothyroidism Diagnosed in the First 3 Months of Life in Newborns Living in North Italy: A Retrospective Cohort Study.

TSH levels hyperthyrotropinemia subclinical hypothyroidism therapy thyroid

Journal

Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936

Informations de publication

Date de publication:
06 Jan 2023
Historique:
received: 16 12 2022
revised: 03 01 2023
accepted: 03 01 2023
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 22 1 2023
Statut: epublish

Résumé

Subclinical hypothyroidism (SH) management in neonatal age opens important questions. We aimed to describe the evolution over time of subclinical hypothyroidism diagnosed in the first three months of life in a population of full-term neonates. A single-center longitudinal retrospective cohort study in a tertiary care center was conducted. We recruited 32 subjects with SH diagnosed within the first three months of life. We collected clinical, biochemical, and ultrasound data for every subject at the first examination and every six months until four years of age. A total of 43.8% of subjects showed stimulating thyroid hormone (TSH) levels over the limit of 10 mUI/L and underwent treatment (Group 1). Eleven subjects started therapy at the first visit, while three subjects started it after a period of observation; 15.6% (Group 2A) showed a trend of TSH decrease and were finally discharged from the follow-up, while 40.6% (Group 2B) showed a TSH level slightly increased, changeless over time. We demonstrated that more than half of newborns with hyperthyrotropinemia did not require substitutive therapy showing a positive trend toward normalization or a remaining slight increase compared to normal levels. Moreover, our study suggests the need for a follow-up over time to check the TSH levels course.

Sections du résumé

BACKGROUND BACKGROUND
Subclinical hypothyroidism (SH) management in neonatal age opens important questions. We aimed to describe the evolution over time of subclinical hypothyroidism diagnosed in the first three months of life in a population of full-term neonates.
METHODS METHODS
A single-center longitudinal retrospective cohort study in a tertiary care center was conducted. We recruited 32 subjects with SH diagnosed within the first three months of life. We collected clinical, biochemical, and ultrasound data for every subject at the first examination and every six months until four years of age.
RESULTS RESULTS
A total of 43.8% of subjects showed stimulating thyroid hormone (TSH) levels over the limit of 10 mUI/L and underwent treatment (Group 1). Eleven subjects started therapy at the first visit, while three subjects started it after a period of observation; 15.6% (Group 2A) showed a trend of TSH decrease and were finally discharged from the follow-up, while 40.6% (Group 2B) showed a TSH level slightly increased, changeless over time.
CONCLUSIONS CONCLUSIONS
We demonstrated that more than half of newborns with hyperthyrotropinemia did not require substitutive therapy showing a positive trend toward normalization or a remaining slight increase compared to normal levels. Moreover, our study suggests the need for a follow-up over time to check the TSH levels course.

Identifiants

pubmed: 36670668
pii: children10010118
doi: 10.3390/children10010118
pmc: PMC9856945
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Endocrinol Invest. 2006 Jul-Aug;29(7):581-93
pubmed: 16957405
J Pediatr. 2000 Jan;136(1):53-6
pubmed: 10636974
Clin Endocrinol (Oxf). 2010 Feb;72(2):264-71
pubmed: 19473184
Acta Paediatr Suppl. 2006 Apr;450:76-85
pubmed: 16817681
Clin Endocrinol (Oxf). 2005 Nov;63(5):560-5
pubmed: 16268809
Thyroid. 2021 Mar;31(3):387-419
pubmed: 33272083
J Clin Endocrinol Metab. 2002 Jul;87(7):3209-14
pubmed: 12107226
J Pediatr. 2014 Jun;164(6):1296-302
pubmed: 24518164
J Pediatr. 2016 Jul;174:71-77.e1
pubmed: 27189684
J Endocr Soc. 2018 Jul 25;2(9):1024-1039
pubmed: 30187015
J Clin Endocrinol Metab. 2008 Jul;93(7):2679-85
pubmed: 18445672
Pediatr Neonatol. 2018 Feb;59(1):3-14
pubmed: 28811156
J Clin Res Pediatr Endocrinol. 2013 Sep 10;5(3):170-3
pubmed: 24072085
Clin Endocrinol (Oxf). 2013 Dec;79(6):832-7
pubmed: 23611595
Eur J Endocrinol. 2013 Jan 17;168(2):263-9
pubmed: 23184911
J Pediatr Gastroenterol Nutr. 2010 Sep;51(3):353-61
pubmed: 20601901
J Clin Endocrinol Metab. 2010 Sep;95(9):4283-90
pubmed: 20591982

Auteurs

Valentina Mancioppi (V)

Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, 28100 Novara, Italy.

Valentina Antoniotti (V)

Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, 28100 Novara, Italy.

Arianna Solito (A)

Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, 28100 Novara, Italy.

Elisabetta Mingoia (E)

Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, 28100 Novara, Italy.

Alice Monzani (A)

Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, 28100 Novara, Italy.

Giulia Genoni (G)

Neonatal and Pediatric Intensive Care Unit, Maggiore della Carità University Hospital, 28100 Novara, Italy.

Ivana Rabbone (I)

Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, 28100 Novara, Italy.

Flavia Prodam (F)

Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, 28100 Novara, Italy.
Endocrinology, Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.
Interdisciplinary Research Center of Autoimmune Diseases, University of Piemonte Orientale, 28100 Novara, Italy.

Simonetta Bellone (S)

Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, 28100 Novara, Italy.
Interdisciplinary Research Center of Autoimmune Diseases, University of Piemonte Orientale, 28100 Novara, Italy.

Classifications MeSH